glp-1 drug market size Size, Share GLP-1 Receptor Agonist Market Size,

Le trsor cach du monstre de Gila [The Hidden Treasure of the Gila Monster]

Made by Eli Lilly, its the same medication as Mounjaro (approved for diabetes) but marketed specifically for obesity treatment

For example, liraglutide in LEADER reduced SBP by a mean of 1.2 mm Hg, 33 while injectable and oral semaglutide in SUSTAIN-6 and PIONEER-6, respectively, achieved mean reductions of 2.6 mm Hg

Liraglutide injection

These drugs are anticipated to overcome the challenges of oral semaglutide, most notably the substantial food-drug interactions and low oral bioavailability (0.4% to 1.0%)

Therefore, the demand for GLP-1 drugs is increasing